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The spike (S) protein of coronavirus, mouse hepatitis virus (MHV), mediates attachment and fusion during viral entry and
cell-to-cell fusion later in infection. By analogy with other viral proteins that induce cell fusion the MHV S protein would be
expected to have a hydrophobic stretch of amino acids that serves as a fusion peptide. Sequence analysis suggests that the
S protein falls within the group of fusion proteins having internal rather than N-terminal fusion peptides. Based on the
features of known viral fusion peptides, we identified two regions (PEP1 and PEP2) of MHV-A59 S2 as possible fusion
peptides. Site-directed mutagenesis and an in vitro cell-to-cell fusion assay were used to evaluate the roles of PEP1 and
PEP2, as well as a third previously identified putative fusion domain (PEP3) in membrane fusion. Substitution of bulky
hydrophobic residues with charged residues within PEP1 affects the fusion activity of the S protein without affecting
processing and surface expression. Similar substitutions within PEP2 result in a fusion-negative phenotype; however, these
mutant S proteins also exhibit defects in protein processing and surface expression which likely explain the loss of the ability
to induce fusion. Thus PEP1 remains a candidate fusion peptide, while PEP2 may play a significant role in the overall structure
or oligomerization of the S protein. PEP3 is an unlikely putative fusion peptide since it is not conserved among coronaviruses
and nonconservative amino acid substitutions in PEP3 have minimal effects on cell-to-cell fusion. © 1998 Academic Press
INTRODUCTION
Mouse hepatitis virus strain A59 (MHV-A59) is a mu-
rine coronavirus with a positive-stranded RNA genome of
approximately 31 kb (Siddell et al., 1983). The coronavi-
rus spike (S) protein forms the peplomer structure on the
viral envelope; each spike is thought to be a dimer or
trimer of S (Cavanagh, 1983). The S protein mediates
binding of virions to the host cell receptor (Collins et al.,
1982), virus cell fusion during entry, and cell-to-cell fusion
at later times postinfection (Vennema et al., 1990). The
MHV S protein is cotranslationally glycosylated to a 150-
kDa form, which is later processed to a 180-kDa form
during intracellular maturation (Spaan et al., 1988). The
180-kDa mature form is cleaved in the Golgi apparatus,
by a host cell protease, into two similarly sized subunits:
amino terminal S1 and carboxy terminal S2 (Frana et al.,
1985; Luytjes et al., 1987; Sturman et al., 1985). It is
believed that the S1 subunit forms the globular head of
the spike, whereas the S2 subunit forms the membrane-
bound stalk portion (de Groot et al., 1987a). Sequence
analysis suggests that the coronavirus spike protein has
the structural features of a type I membrane protein
(Spaan et al., 1988), including a transmembrane domain
near the carboxy terminus of S2 and a hydrophobic
signal peptide at the N-terminus of S1. Other structural
motifs include two heptad repeat domains in S2, the
shorter of which is adjacent to the transmembrane do-
main and is a leucine zipper motif (Britton, 1991). The S1
subunit is believed to interact with receptor (Cavanagh et
al., 1986; Taguchi, 1995). A receptor binding activity has
been demonstrated using a recombinant protein contain-
ing the amino terminal 330 residues of the S1 subunit of
MHV-JHM (Kubo et al., 1994). Recombinant S protein,
expressed in tissue culture using a vaccinia virus-based
expression system, is capable of inducing cell-to-cell
fusion (Bos et al., 1995; de Groot et al., 1989), demon-
strating that the S protein alone is sufficient for the
induction of cell-to-cell fusion. In spite of the important
role played by the S protein in viral entry and cell-to-cell
fusion, little is known about the fusion domain which is
directly responsible for the fusion event.
A common feature of viral fusion proteins is the pres-
ence of a fusion peptide, which is believed to participate
directly in the fusion process (White, 1992). Fusion pep-
tides are typically composed of 16 to 26 amino acid
residues and conserved within, but only rarely among,
virus families. They are relatively hydrophobic and gen-
erally show an asymmetric distribution of hydrophobicity
when modeled into an a helix; they are also rich in
alanine and glycine. The majority of known fusion pep-
tides are found at the N-terminus of the membrane-
anchored subunit of viral fusion proteins that undergo
proteolytic cleavage during their maturation (White,
1990). The cleavage is believed to be necessary in order
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to expose the peptide itself to facilitate the fusion pro-
cess. However, not all fusion proteins undergo proteo-
lytic cleavage and there are examples of fusion peptides
that exist internally in the membrane-anchored subunit
(White, 1990). Besides having the above common fea-
tures, these internal fusion peptides are bounded by
charged residues on both ends and may contain a pro-
line residue in the center.
Although the MHV S protein is cleaved during process-
ing, the N-terminus of the membrane-anchored S2 subunit
does not contain a hydrophobic, conserved region. More-
over, not all coronavirus S proteins (for example, feline
infectious bronchitis virus and transmissible gastroenteritis
virus) undergo cleavage during maturation (Cavanagh,
1995). Thus it is likely that the coronavirus S protein has an
internal fusion peptide. Using the properties common to
other fusion peptides (discussed above), we have detected
two fusion peptide-like regions, PEP1 and PEP2, in the S2
subunit of the MHV-A59 S protein (Fig. 1). We performed
mutational analysis of these two regions as well as of a
third peptide (PEP3) that was previously proposed as a
possible fusion domain (Chambers et al., 1990). The effects
of amino acid substitutions within these regions on S-
induced cell-to-cell fusion, protein processing, and cell sur-
face expression were examined. The data suggest that
mutations in both PEP1 and PEP2 have a dramatic effect on
the ability of S to induce cell-to-cell fusion. While mutations
in PEP1 have little effect on processing of the S protein,
mutations within PEP2 result in the loss of the ability of S to
be processed and transported to the plasma membrane.
Therefore PEP1 remains a likely candidate fusion peptide,
whereas PEP2 may play a role in maintaining the overall
structure of S or oligomerization. PEP3 appears unlikely to
be a fusion peptide candidate as amino acid substitutions
within this peptide have little effect on fusion.
RESULTS
Identification of candidate fusion peptides
Using known characteristics of fusion peptides, in-
cluding sequence conservation, hydrophobicity, and the
ability to be modeled as a sided a helix, we identified two
putative fusion peptides, PEP1 and PEP2, in the S2 sub-
unit of the MHV-A59 S protein. Their positions within the
S2 subunit are shown in Fig. 1A along with identified
functional domains such as the two heptad repeats and
the transmembrane domain. PEP1 is located within the
longer heptad repeat and PEP2 is located between the
two heptad repeats. A third candidate fusion domain,
PEP3, previously identified based on its hydrophobicity
and its proximity to the heptad repeats (Chambers et al.,
1990), is also shown. The MHV-A59 S protein sequence
was aligned with those from other coronaviruses using
the computer program CLUSTAL V (Higgins et al., 1992).
Regions corresponding to PEP1, PEP2, and PEP3 are
shown in Fig. 1B. Since coronaviruses are divided into
three antigenic groups (Cavanagh, 1995), two represen-
tative coronaviruses from groups I (FIPV, TGEV) and II
(MHV, BCV) were shown as well as IBV, which is the sole
member of group III.
PEP1 shows several of the properties of known fusion
peptides. It is conserved among coronaviruses and bor-
dered by charged or polar residues. Most of the un-
matched amino acid residues in PEP1 are conservative
substitutions. Besides sequence conservation, modeling
PEP1 into an a helix shows a clear asymmetric distribu-
tion of bulky hydrophobic residues (Fig. 2A). Analysis of
the hydrophobicity showed that PEP1 has an overall
hydrophobicity index (H.I.) of 0.73. The H.I. for the hydro-
phobic side is 1.7, while the H.I. for the hydrophilic side is
20.5. PEP1 is rich in alanine and glycine residues (35%).
PEP2 also has some features typical of fusion peptides
in addition to sequence conservation. For example, PEP2
is bordered by charged residues and showed an asym-
metric distribution of hydrophobicity when modeled into
an a helix (Fig. 2B). The H.I.s for the hydrophobic and
hydrophilic sides are 0.82 and 20.05, respectively. While
PEP2 does not have alanine and glycine residues, it
contains a central proline residue, another typical feature
of internal fusion peptides (White, 1990). Alignment of
PEP3 indicates that this region is less conserved than
PEP1 and PEP2 (Fig. 1B) among the three antigenic
groups of coronaviruses. Furthermore, it is not bordered
by charged residues and not predicted to form an a helix
with an asymmetric distribution of bulky hydrophobic
residues.
Quantitative cell-to-cell fusion assay
for the MHV S protein
Using the quantitative fusion assay described in detail
under Materials and Methods, we examined the effects
of amino acid substitutions on the membrane fusion
activity of the S protein. The S gene was expressed in
murine DBT cells by infection with vaccinia virus vTF7-3
to supply the T7 RNA polymerase, followed by transfec-
tion with a plasmid containing the S gene downstream of
a T7 RNA polymerase promoter. Another group of DBT
cells was transfected with a plasmid containing the
Escherichia coli lacZ gene, also downstream of the T7
RNA polymerase promoter. Only when cell fusion occurs
between a cell expressing the S gene and a cell con-
taining the lacZ plasmid is the lacZ gene transcribed and
b-galactosidase subsequently produced. Syncytia were
observed and b-galactosidase activities were measured
either by an in situ assay in which syncytia were stained
blue in the presence of 5-bromo-4-chloro-3-indolyl-b-D-
galactopyranoside (X-Gal) or by a quantitative assay us-
ing CPRG (chlorophenol red-b-D-galactopyranoside) as
the substrate (see Materials and Methods). Such an
assay is illustrated in Fig. 3. In cells infected with vTF7-3
and mock transfected, only tiny blue background stains
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were detected (Fig. 3A). However, in cells infected with
vTF7-3 and transfected with plasmid containing the wild-
type S gene, fusion of donor cells and the surrounding
recipient cells were observed and the resulting syncytia
stained blue in the presence of X-Gal (Fig. 3B). The size
of the blue stains was equivalent to the size of the
induced syncytia (Fig. 3B). The mutant S protein A974D-
A976D (described further below) failed to induce fusion,
resulting in a fusion phenotype similar to that of mock-
transfected cells (Fig. 3C). The fusion-positive mutant S
protein S975D (described further below) exhibited a phe-
notype similar to that of the wild-type S protein (Fig. 3D).
The levels of the b-galactosidase activities for the par-
allel samples were also quantitated to demonstrate that
the in situ assay reflects the levels of fusion (Fig. 3E).
Values indicating the level of fusion were expressed as
the percentage of wild-type b-Gal activity after subtract-
ing the background value of mock-transfected cells. The
FIG. 1. Hydrophobic peptides PEP1, PEP2, and PEP3 in the MHV-A59 spike protein S2 subunit. (A) Schematic diagram of S2 showing the relative
locations of PEP1, PEP2, and PEP3. The entire S2 subunit of the MHV-A59 S protein is represented by a thin black line. PEP1, PEP2, and PEP3 are
represented by the black boxes. The two heptad repeats (HR1 and HR2) in the S2 subunit are represented by hatched boxes. The transmembrane
domain is represented by a gray box. (B) Sequence homology of PEP1, PEP2, and PEP3 from different coronaviruses. The S protein sequences of
coronaviruses MHV strain A59 (Luytjes et al., 1987), BCV strain F15 (Boireau et al., 1990), IBV strain M41 (Binns et al., 1986), FIPV strain 79-1146 (de
Groot et al., 1987b), and TGEV strain TFI (Chen et al., 1993) were aligned by the computer program CLUSTAL V. The regions corresponding to PEP1,
PEP2, and PEP3 are shown. Their corresponding positions in the primary sequence are shown in brackets. At the bottom of each alignment, asterisks
are used to indicate positions with identical amino acid residues, and a dot for positions with conservative amino acid changes. The positions with
nonconservative changes are not indicated by any symbols.
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average size of syncytia usually corresponded to the
b-Gal percentage values. A percentage of 0 to 10% indi-
cated a fusion-negative phenotype, while values over
70% of the wild type indicated a fusion phenotype similar
to that of the wild type. Values between 10 and 70%
indicated intermediate fusion phenotypes.
Analysis of spike proteins with amino acid
substitutions in PEP1
To determine the importance of the asymmetric distri-
bution of hydrophobicity in the induction of cell-to-cell
fusion, as predicted by the ability to model this peptide
as a sided a helix (Fig. 2A), nonconservative and con-
servative amino acid substitutions were introduced in
PEP1 to target representative bulky hydrophobic resi-
dues (F977K, F977L, L981K, L981I) and polar or charged
residues (S975D, N978D, N978L, D986V-D989V). The im-
portance of the presence of small amino acid residues,
such as alanine or glycine, in the mechanism of fusion
was tested by substituting them with charged residues
(A974D, A976D), bulky hydrophobic residues (A976V), or
both at two different positions (A974D-A976D, A974D-
A974V).
Since viral fusion proteins undergo complex posttrans-
lational processing before arriving at the cell surface, it is
possible that any alteration of the fusogenic ability of the
S protein may be caused by defects in protein process-
ing and/or transport rather than to the fusion process
itself. Proteins that are defective in processing, for ex-
ample either misfolded or misassembled, are often re-
tained in the ER and thus not expressed on the cell
surface (Doms et al., 1993). Therefore, the level of sur-
face expression is a good indicator as to whether mutant
proteins are generally folded correctly. We examined the
surface expression of the above PEP1 mutant proteins by
flow cytometry analysis to determine whether they were
indeed processed and transported to the cell surface. As
shown in Fig. 4A, the flow cytometry histogram of the
PEP1 mutant A974D-A976D is similar to that of the wild-
type S protein. The histograms of all the other PEP1
mutants were similar as well (data not shown). Quanti-
tation of the levels of surface expression (Table 1) indi-
cates that all of the PEP1 mutant S proteins were ex-
pressed on the cell surface at levels similar to that of the
wild-type S protein, suggesting that their overall confor-
mation was not altered. Thus any alteration of fusion
caused by these PEP1 mutations is not likely due to
overall conformational changes, but rather likely attrib-
uted to a direct influence on the fusion process.
All mutant PEP1 S proteins were assayed for fusion
using both in situ and quantitative fusion assays, per-
formed as shown in Fig. 3, using the vTF7-3-infected and
wild-type S gene-transfected cells as positive controls
and vTF7-3-infected and mock-transfected cells as neg-
ative controls. The results were summarized in Table 1.
Substitution of hydrophobic residues with charged resi-
dues generated the fusion negative phenotype. Both
F977K and L981K mutations reduced the b-galactosi-
dase activity to the background level. However, replace-
ment of the same residues with other hydrophobic amino
acids (F977L, L981I) did not reduce fusion. These results
suggest that maintenance of the hydrophobicity at the
nonpolar side is important for fusion. Substitution of
polar or charged residues on the hydrophilic side of the
predicted sided helix had less impact on fusion (Table 1,
PEP1). Increasing the hydrophobicity on the polar side
(N978L, D986V-D989V) resulted in a partially impaired
fusion phenotype. Increasing the hydrophilicity by sub-
stituting serine at position 975 with an aspartic acid
residue (S975D) did not affect fusion. However, this was
not true for the N978D mutant, which failed to maintain
the wild-type fusion phenotype. Unlike the serine residue
at position 975, this Asn residue is conserved among all
coronavirus spike proteins (Fig. 1B). Substitutions of ala-
TABLE 1
Fusion Activity and Surface Expression of Wild-Type
and Various Mutant S Proteins
Construct Fusion activitya Surface expressionb
Wild type 100 100
PEP1
L981I 102 92
L981K 4 87
F977L 96 86
F977K 6 98
N978L 38 92
N978D 44 89
S975D 94 85
D986V–D989V 46 107
A974D 42 103
A976D 57 87
A976V 50 80
A974D–A976D 4 98
A974D–A976V 5 83
PEP2
L1102K 7 1
V1103K 9 1
P1107K 9 3
L1110K 6 3
I1113K 5 2
PEP3
M936L 116 ND
M936K 87 ND
P938L 105 ND
P938K 48 ND
a Reported as percentage of b-galactoside produced in samples
using wild-type S protein (see Materials and Methods). All data are
averages of triplicates from one experiment. The experiments were
repeated five times with a standard deviation of less than 25%.
b Reported as the percentage of the mean fluorescent intensity
values measured for samples expressing the wild-type S protein after
subtracting background values obtained for mock-transfected samples.
Experiments were repeated twice with a standard deviation of less
than 20%. ND, Not determined.
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nine residues with either a charged residue (A974D or
A976D) or a bulky hydrophobic residue (A976V) resulted
in a partially reduced fusion phenotype regardless of
hydrophobicity. Double mutants A974D-A976D and
A974D-A976V both displayed a fusion-negative pheno-
type, suggesting that the effects of the separate mutation
may be additive in the double mutants. The reduced
fusion level in A976V mutant S proteins suggests that the
alanine residue is required not merely for hydrophobicity.
The reduction in fusion observed with the N978D mutant
also suggests that conservation at some residues is
more of a factor in fusion than hydrophilicity alone.
Mutational analysis of PEP2 and PEP3
PEP2 contains a high percentage of bulky hydrophobic
residues and may also be modeled as a sided helix (Fig.
2B). Thus we determined the effect on fusion of substi-
tution of hydrophobic residues on the nonpolar face with
the charged lysine residue. All such mutant S proteins
appear to have lost the ability to induce fusion (Table 1).
Consistent with this, no syncytia were observed in the in
situ fusion assay. We examined the cell surface expres-
sion of PEP2 spike mutants using flow cytometry analy-
sis. Figure 4B demonstrates that, for one representative
PEP2 mutant, spike protein is not expressed on the cell
surface. Similar results were obtained for all the PEP2
mutants (data not shown); these results are summarized
in Table 1. Thus, PEP2 mutant S proteins differed from the
PEP1 mutant proteins in that the former were not trans-
ported to the cell surface. Therefore, the fusion-negative
phenotype of these PEP2 mutants is likely to be an
indirect effect of overall conformational changes which
prevents transport and expression on the cell surface
(Table 1).
To investigate whether the PEP2 mutants were de-
fective in protein transport, they were assayed for
endoglycosidase H (endo H) resistance (Fig. 5). During
transport from the endoplasmic reticulum (ER) to the
Golgi apparatus, glycoproteins are modified by acqui-
sition of oligosaccharides that are resistant to endo H
digestion (Kornfeld and Kornfeld, 1985). Proteins that
are not processed properly usually fail to gain this
resistance. Cells transfected with the plasmids ex-
pressing wild-type and PEP2 mutant proteins were
labeled with [35S]methionine and cysteine for 1 h and
then lysed or labeled and chased with an excess of
unlabeled methionine and cysteine before lysis. Pro-
teins were immunoprecipitated with the AO4 anti-S
sera, treated with endo H, and analyzed by SDS–PAGE.
Endo H resistance was not detectable after 1 h label-
ing of either wild-type or mutant proteins (Fig. 5A).
However, after a 2-h chase, a portion of the wild-type
S proteins were processed into an endo H-resistant
form (Fig. 5B). These results are consistent with the
observation that the processing of S expressed using
a vaccinia expression system has a half-time of ap-
proximately 3 h (Vennema et al., 1990). Interestingly,
the fraction of the wild-type S protein that became
endo H resistant is not particularly high. This is similar
to the observation made in another study of the MHV-
A59 S protein (Bos et al., 1995). Endo H-resistant forms
of the PEP2 mutants were not detected even after a
2-h chase, indicating that these mutant proteins were
unable to be transported from the ER to the medial
FIG. 2. Schematic diagram of the amino acid sequences of PEP1 and
PEP2 as arranged in an a helical wheel. PEP1 (A) and PEP2 (B) are
modeled as a helical wheels. The amino acid residues that were
subject to mutagenesis are numbered according to their corresponding
positions in the primary sequence. The left side of the dotted line
indicates the hydrophobic face, while the right side indicates the
hydrophilic side. The starting amino acid residue of each wheel is
marked by ‘‘†’’, while the ending residue is marked by ‘‘*’’.
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Golgi complex. In contrast, an endo H-resistant form of
the fusion-negative PEP1 mutant A974D-A976D was
detected after a 2-h chase. This protein was also
expressed on the cell surface as described above
(Table 1), suggesting that correct processing of S
correlates with its surface expression.
FIG. 3. b-Galactosidase expression and syncytia formation as visualized by the in situ assay and quantitated by colorimetric assay. In situ assay
(A–D) and quantitative colorimetric assay (E) were carried out according to the Materials and Methods. (A) Cells infected with vTF7-3 and mock
transfected; (B) cells infected with vTF7-3 and transfected with pINT2 containing the wild-type S gene; (C) cells infected with vTF7-3 and transfected
with pINT2 containing the A974D-A976D mutant S gene; (D) cells infected with vTF7-3 and transfected with pINT2 containing the S975D mutant S
gene; (E) The production of b-galactosidase from these same samples was quantitated. The vertical axis indicates the percentage of wild-type b-Gal
activity after subtracting the background.
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PEP3 (Fig. 1) was previously proposed as a possible
fusion domain based on its hydrophobicity and location
adjacent to the heptad repeat domains (Chambers et al.,
1990). However, this region is less conserved than PEP1
and PEP2. We performed a limited amount of mutagen-
esis within this region to determine the effects on fusion.
Substitution of the methionine residue at position 936
with lysine (M936K) or leucine (M936L) did not effect
fusion. However, while substitution of the proline residue
at position 938 with lysine (P938K) partially impaired
fusion, replacing the same proline residue with a leucine
residue did not have any effect on fusion. The results
suggest that PEP3 is unlikely to be a putative fusion
peptide.
DISCUSSION
Although studies of the coronavirus S protein reveal
that S alone is sufficient to induce cell-to-cell fusion in
the absence of other coronavirus proteins, little is known
about the fusion peptide domain of the S protein. Using
the characteristics of known fusion peptides including
the observation that they may be modeled as a helices
with an asymmetric distribution of hydrophobicity, we
identified two conserved hydrophobic regions, PEP1 and
PEP2, in the MHV-A59 S protein S2 subunit, as candidate
fusion peptides. Site-directed mutational analysis was
used to examine the significance of individual amino
acid residues within each of these peptides in cell-to-cell
FIG. 4. Flow cytometry analysis of surface expression of wild-type and mutant S proteins. BHK-21 cells were infected with vTF7-3 and transfected
with plasmids containing wild-type or mutant S genes. Four hours after transfection, cells were subject to flow cytometry analysis for surface
expression of S proteins (see Materials and Methods). Fluorescent histograms of a PEP1 mutant (A974D-A976D) and a PEP2 mutant (P1107K) are
shown side by side with the corresponding wild-type controls. Two wild-type controls were shown because A and B represent different experiments.
The histogram obtained from a mock-transfected negative control (shown in gray lines) was embedded in each histogram. The X axis indicates the
arbitrary fluorescent intensity values shown in log scale. The Y axis indicates the number of cells. The mean fluorescent intensity values (MFIV) were
calculated and the surface expression of each mutant relative to wild type was determined using the following formula: (MFIVsample 2 MFIVmock)/
MFIVwild type 2 MFIVmock) 3 100.
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fusion. A third previously identified peptide was also
examined as a possible fusion domain. The mutagenesis
results indicate that PEP1 remains the most likely can-
didate fusion peptide. All PEP1 mutants we analyzed,
including the ones that displayed a fusion-negative phe-
notype, were expressed on the cell surface at a level
similar to that of the wild-type protein. In contrast, the
group of PEP2 mutants were defective in a step in pro-
cessing or intracellular transport; thus the negative fu-
sion phenotype was likely due to the lack of expression
on the cell surface rather than to a direct effect on the
ability to induce cell-to-cell fusion. Mutations in PEP3
had less effect on the fusogenic ability of S; this along
with the fact that this domain is not well conserved
among coronaviruses makes it an unlikely candidate
fusion peptide.
A current hypothesis on how viral fusion proteins in-
duce membrane fusion is that fusion involves a confor-
mational change of fusion proteins which is triggered by
low pH or another factor(s) (White, 1992). The altered
conformational change allows the hydrophobic fusion
peptide to interact with the target membrane. The fusion
peptide is postulated to act as a sided insertional helix.
The hydrophobic face of the helix inserts into the mem-
brane with an oblique orientation, leading to the disrup-
tion of the membrane structure (Harter et al., 1989; White,
1990, 1992). Alteration of this hydrophobic face would
affect this interaction. The perturbation of the hydropho-
bic face in PEP1 by substitution of bulky hydrophobic
residues with charged ones may prohibit the insertion,
thus abrogating the fusogenic activity. Other less drastic
amino acid substitutions may result in less severe ob-
struction of this type of interaction, thus having less
drastic effect on fusion.
PEP1 is located within the longer of the two heptad
repeat regions in S2. Since heptad repeat motifs are
typical of regions that form a helical coiled coil struc-
tures (Cohen and Parry, 1986), it is likely that PEP1
adopts an a helical conformation as part of this coiled
coil structure. PEP1 is distinguished from the rest of
the heptad repeat region in that it possesses several
features common to known viral fusion peptides.
Those include sequence conservation among corona-
viruses, hydrophobicity, richness in alanine and gly-
cine residues, and the ability to be modeled into a
sided helix and bounded by charged residues. Studies
of heptad repeat regions in many viral fusion proteins
have revealed that they are also essential for mem-
brane fusion (Buckland et al., 1992; Dubay et al., 1992;
Sergel-Germano et al., 1994). Although fusion peptides
are generally found adjacent to heptad repeats but not
within the heptad repeat, there is no indication that
fusion peptides cannot reside in a heptad repeat. It is
postulated that heptad repeats may also be able to
insert into membranes to help elicit fusion because of
the amphipathic nature of their helices (Segrest et al.,
1992; Sergel-Germano et al., 1994). Synthetic peptides
representing part of the influenza virus HA heptad
repeat region have been shown to insert reversibly
into phospholipid vesicles under endosomal pH con-
ditions (Yu et al., 1994). Amphipathic a helices of a
protein molecule may associate with membranes
spontaneously (DeGrado, 1993; Segrest et al., 1990).
Melittin, an amphipathic helical peptide, is capable of
inducing membrane fusion due to a local disruption of
the lipid bilayer (Dempsey, 1990). Thus, fusion pep-
tides and heptad repeats may be indispensable parts
of an integrated fusion machinery whereby fusion pep-
tides may or may not be located independently from
heptad repeats.
PEP1 has 35% alanine and glycine residues. Although
substitution of one alanine residue by another charged
one (A976D) reduced fusion, substitution with a more
hydrophobic valine residue (A976V) also reduced fusion,
suggesting that alanine residues may have roles in fu-
sion other than the maintenance of hydrophobicity. Re-
placement of glycine residues by valine residues in the
HIV gp41 fusion peptide either abrogated or reduced
fusion (Delahunty et al., 1996). It is postulated that the
presence of small glycine/alanine residues in the fusion
peptide provide the right balance of amphipathicity nec-
essary in mediating fusion for influenza virus (White,
FIG. 5. Endoglycosidase H analysis of the PEP2 mutants. Cells
expressing the wild-type or the PEP2 mutant S proteins were metabol-
ically labeled for 1 h with 35S Express Labeling Mix and either analyzed
directly (A) or incubated further for 2 h in the presence of excess
methionine and cysteine (B). Cells were lysed and S proteins were
immunoprecipitated using anti-S AO4 serum. Half of each sample was
digested with Endo Hf (1) or incubated without the enzyme (2). Wild-
type S gene (lanes 1, 2), L1102K mutant (lanes 3, 4), V1103K mutant
(lanes 5, 6), P1107K mutant (lanes 7, 8), L1110K mutant (lanes 9, 10),
PEP1 mutant A974D–A976D (lanes 11, 12). The little black spot above
the endo H-sensitive spike band in lane 6 was caused by a slight gel
crack.
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1992). Furthermore, studies on the SIV gp32 fusion pep-
tide suggest that the presence of these residues may be
important for oblique insertion of the fusion peptide into
the target membrane (Horth et al., 1991).
Substitution of bulky hydrophobic residues with
charged lysine residues in all constructed PEP2 mutants
abolished the fusogenic ability of S. However, this is
likely due to a defect in processing or transport to the cell
membrane rather than to a direct effect on the fusion
process. The failure to detect an endo H-resistant form of
S for the PEP2 mutants (Fig. 5) suggests that this region
plays a role in the maturation of S. For example, muta-
tions in PEP2 may cause individual molecules to be
misfolded, leading them to form aggregates even before
appropriate oligomerization occurs. Such aggregates are
normally retained in the ER (Marquardt and Helenius,
1992). Consistent with our data are studies in which
Gallagher (1996) demonstrated that membrane fusion
induced by the MHV-JHM S protein was inhibited by
modification of Cys-1163 and suggested that this was
likely due to dramatic changes in S protein structure.
Sequence alignment of MHV-JHM and MHV-A59 indi-
cates that this cysteine residue corresponds to a ty-
rosine residue in MHV-A59, which is located in the PEP2
region. Furthermore, studies of two temperature-sensi-
tive MHV-A59 mutants in which the endo H-resistant
form of S was not detectable at nonpermissive temper-
atures was caused by the lack of oligomerization
(Luytjes et al., 1997), albeit the location of these muta-
tions is not known. Appropriate oligomerization of many
other viral proteins is required for them to be transported
from ER to Golgi, where endo H resistance is obtained
(Doms et al., 1993).
We have analyzed the roles of three hydrophobic re-
gions in the MHV-A59 S protein in S-induced cell-to-cell
fusion. The results of the mutational analysis indicate
that PEP1 is likely to be directly involved in fusion, while
PEP2 may play a role in maintenance of structure and/or
processing of S. Although this study provides insights
into identifying the structural elements of S involved in
fusion, the molecular details of the fusion mechanism
remains unclear. Mutational analysis of PEP1 and PEP2
indicates only that these regions are necessary for the S
protein to assume a fusion competent conformation.
Whether either of these two regions is a fusogenic pep-
tide needs to be determined by biophysical studies using
liposomes. Similar studies have been conducted on fu-
sion peptides for other proteins such as HIV gp41 (Nieva
et al., 1994), influenza virus HA2 (Luneberg et al., 1995),
and sperm surface protein PH-30 (Muga et al., 1994).
Such biophysical studies of the S protein, together with
the elucidation of the three-dimensional structure of S,
would greatly help the understanding of the fusion
mechanism.
MATERIALS AND METHODS
Mutagenesis of the MHV-A59 spike gene
Plasmid pINT2 contains a cDNA copy of the entire
wild-type MHV-A59 S gene, cloned into the SacI and
BamH I sites of pBlueScript II (KS1) (Stratagene), the
expression of which is under the control of the T7 RNA
polymerase promoter. The HindIII site of the S gene in
pINT2 was modified to an AseI site by the introduction of
silent mutations in codons 173 and 174. The mutant S
plasmid clones were generated by oligonucleotide-di-
rected PCR mutagenesis (Ausubel et al., 1989), using
pINT2 as the template. For the PEP1 or PEP3 region,
desired nucleotide changes were introduced into a PCR-
amplified fragment using the 59 flanking primer wz157
(59-AACACTGCATGCAGGCAG-39), the 39 flanking primer
wz175 (59-ATTAATACGCGTGGTTTGGC-39), and the cor-
responding mutagenic primers listed in Table 2. The PCR
fragments were digested with BbsI and MluI and cloned
into the corresponding sites of pINT2. For the PEP2
mutants, primers wz115 (59-AGCAAAAGCCCAGATAGA-
39) and wz11 (59-GGGGGATCCAGGTAGC-39) were used
as the 59 and 39 flanking primers, respectively, along with
the corresponding mutagenic primers listed in Table 2.
The resulting mutant plasmids were generated by sub-
cloning the MluI–NdeI-digested mutant PCR fragments
into the corresponding sites of pINT2. The presence of
specific mutations in all constructs was verified by DNA
sequencing.
Fusion assay
Spike-induced cell-to-cell fusion was examined by us-
ing expression of the E. coli lacZ gene to monitor the
level of fusion, in an assay adapted from Nussbaum et al.
(1994). Briefly, one group of DBT cells was seeded onto
a 96-well plate (Falcon) to be used as donor cells. The
second group of DBT cells was seeded into a 80-cm2
tissue culture flask (Nunclon) as recipient cells. After
overnight incubation at 37°C, cells from the donor cell
group were infected with vaccinia virus vTF7-3 (Fuerst et
al., 1986) at 5 PFU/cell for 1 h at 37°C and then trans-
fected with plasmids (0.2 mg/well) containing either wild-
type or mutant S genes using lipofectin (GIBCO/BRL)
according to the manufacturer’s protocol. The recipient
cells were transfected with the plasmid pG1NTbGal (10
mg/flask) containing the E. coli lacZ gene under the
control of the T7 RNA polymerase promoter (Nussbaum
et al., 1994). The efficiency of lipofection in this and all
the other experiments described below was 20 6 5%, as
determined by the percentage of blue cells visualized by
staining with X-Gal after cells were infected with vTF7-3
and then transfected with pG1NTbGal. After 4 h, the
donor cells were washed once with Dulbecco’s modified
Eagle’s medium (DMEM) and resupplied with DMEM.
The recipient cells were trypsinized, washed once with
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DMEM, resuspended in DMEM, plated on top of the
donor cell monolayer, and incubated overnight. A 3:1
excess of recipient cells to donor cells was used to
ensure that donor cells fuse with the surrounding recip-
ient cells. For the in situ staining assay, cells were fixed
at 4°C for 5 min with 2% formaldehyde and 0.2% glutar-
aldehyde. The monolayers were overlaid with X-Gal so-
lution (5 mM potassium ferricyanide, 5 mM potassium
ferrocyanide, 2 mM MgCl2, 1 mg/ml X-Gal) and blue stain
was observed after incubation at 37°C for 4 h. For quan-
titation of b-galactosidase activity, cell monolayers were
lysed with 1% NP-40. Equal amounts of lysates and
CPRG substrate solution (16 mM CPRG, 120 mM
Na2HPO4 z 7H2O, 80 mM NaH2PO4 z H2O, 20 mM KCl, 2
mM MgSO4 z 7H2O, 10 mM b-mercaptoethanol) were
mixed and substrate hydrolysis rates were measured at
570 nm using a microplate absorbance reader (Molecu-
lar Devices). The amount of b-galactosidase was calcu-
lated using purified E. coli b-galactosidase (Boehringer
Mannheim) as standard.
Metabolic labeling with [35S]methionine and cysteine
DBT cell monolayers were infected with vTF7-3 at 5
PFU/cell. After 1 h at 37°C, cells were washed once with
DMEM and transfected with 2 mg of plasmid containing
either wild-type or mutant S genes as described above.
After 4 h, cells were washed once with methionine-free
DMEM and incubated for 1 h with 35S Express Protein
Labeling Mix (110 mCi/ml; NEN/Dupont) in methionine-
free DMEM. Cells were either lysed immediately or in-
cubated further for 2 h with DMEM supplemented with
excess unlabeled methionine and cysteine (2 mM each)
before lysis with ice-cold lysis buffer [50 mM Tris–HCl
(pH 7.5), 150 mM NaCl, 0.1% SDS, 1% Nonidet P-40, 0.5%
sodium deoxycholate, 10 mM phenylmethylsulfonyl fluo-
ride]. Lysates were centrifuged for 10 min at 13,000 g at
4°C to pellet cell debris and nuclei. The supernatants
were stored in a 280°C freezer until further analysis.
Immunoprecipitation and endoglycosidase H analysis
For immunoprecipitation, lysates containing equal
amounts of radioactive label (4 3 106 TCA-precipitable
cpm) were diluted with 1 ml of immunoprecipitation (IP)
buffer [50 mM Tris–HCl (pH 7.5), 150 mM NaCl, 0.1 mM
EDTA, 0.5% Tween 80, 1 mM phenylmethylsulfonyl fluo-
ride] containing 5 ml of anti-S AO4 goat serum (kindly
provided by Dr. K. Holmes, Denver, Colorado) and 30 ml
of Protein A–Sepharose 6MB beads (Pharmacia Biotech;
diluted 1:1 by the IP buffer). The mixture was incubated
overnight at 4°C. Beads were collected by centrifugation
and washed twice with 1 ml of ice-cold IP buffer, resus-
pended in 20 ml of 10 mM Tris z HCl (pH 6.8), 0.4% SDS,
TABLE 2
Oligonucleotides Used for the PCR Mutagenesis
Name Positiona Sequenceb Purposec
wz16 2943–2981 GGGTGCTATCCAGGTTGGGTTTGTTGCAACCAATTCTGC D986V–D989V
wz123 2908–2949 CAAAAGATGATTGCTAGTGCTaagAACAATGCGCTGGGTGCT F977K
wz124 2920–2963 GCTAGTGCTTTTAACAATGCGaaGGGTGCTATCCAGGATGGGT L981K
wz111 2904–2940 GAACCAAAAGATGATTGCTgaTGCTTTTAACAATGCG S975K
wz110 2904–2939 GAACCAAAAGATGATTGaTAGTGCTTTTAACAATGC A974D
wz17 2904–2939 GAACCAAAAGATGATTGaTAGTGaTTTTAACAATGCG A974D–A976D
wz153 2920–2964 GCTAGTGCTTTTAACAATGCGaTtGGTGCTATCCAGGATGGG L981I
wz154 2908–2949 CAAAAGATGATTGCTAGTGCTcTTAACAATGCGCTGGGTGCT F977L
wz155 2911–2952 AAGATGATTGCTAGTGCTTTTgACAATGCGCTGGGTGCTATC N978D
wz156 2911–2952 AAGATGATTGCTAGTGCTTTTctCAATGCGCTGGGTGCTATC N978L
wz162 2905–2946 AACCAAAAGATGATTGCTAGTGaTTTTAACAATGCGCTGGGT A976D
wz163 2905–2946 AACCAAAAGATGATTGCTAGTGtTTTTAACAATGCGCTGGGT A976V
wz128 3286–3325 GGTAATCATATATTATCTaagGTCCAGAATGCGCCTTATG L1102K
wz129 3286–3328 GGTAATCATATATTATCTCTTaagCAGAATGCGCCTTATGGCT V1103K
wz130 3301–3340 TCTCTTGTCCAGAATGCGaagTATGGCTTATATTTTATAC P1107K
wz131 3310–3349 CAGAATGCGCCTTATGGCaagTATTTTATACACTTCAGCT L1110K
wz133 3319–3357 CCTTATGGCTTATATTTTAagCACTTCAGCTATGTGCCA I1113K
wz158 2785–2826 ACCGGTGCTACTGCGGCAGCTcTGTTCCCACCGTGGTCAGCA M936L
wz159 2785–2826 ACCGGTGCTACTGCGGCAGCTAaGTTCCCACCGTGGTCAGCA M936K
wz160 2791–2832 GCTACTGCGGCAGCTATGTTCCtACCGTGGTCAGCAGCTGCC P938L
wz161 2791–2832 GCTACTGCGGCAGCTATGTTCaagCCGTGGTCAGCAGCTGCC P938K
a The region of the MHV-A59 S sequence covered by each oligonucleotide is marked by the positions of the 59 and 39 nucleotides separated by
a dash. The position of the 59 nucleotide is shown first for each oligonucleotide. The positions are numbered in reference to the first nucleotide for
the S coding sequence.
b Oligonucleotide sequences are shown starting with the 59 nucleotide. Capital letters indicate that the sequence is exactly the same as the pINT2
sequence. Lowercase letters indicate the mismatched nucleotides designed for specific mutations.
c The designated amino acid substitutions resulted from using each mutagenic primer are listed.
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and heated at 95°C for 5 min. Samples were divided into
two 10-ml aliquots and mixed with either 10 ml of 50 mM
of sodium citrate (pH 5.5) containing 1 mU/ml of Endo Hf
(New England Biolabs) or buffer alone. Samples were
incubated at 37°C overnight and analyzed by SDS–PAGE
(Sambrook et al., 1989). Gels were stained with Coomas-
sie brilliant blue R-250, destained, treated with sodium
slicylate (Chamberlain, 1979), dried, and exposed to X-
ray film at 280°C.
Surface expression by flow cytometry analysis
Infection with vTF7-3 followed by transfection with 4
mg of plasmid was carried out as above except that
BHK-21 cells were used. Four hours after transfection,
cells were washed once with DMEM and incubated
overnight with DMEM supplemented with 2% fetal bovine
serum. Cells were then detached by EDTA, washed once
with ice-cold FACS buffer (2% fetal bovine serum diluted
in phosphate buffer saline), and resuspended in 100 ml of
FACS buffer containing 2 ml of anti-S antibody AO4. After
1 h incubation on ice, the cells were washed twice with
cold FACS buffer and then resuspended with 100 ml of
FACS buffer containing fluorescein-conjugated rabbit an-
ti-goat IgG (Cappel). The cells were incubated on ice for
1 h, washed twice with cold FACS buffer, and analyzed
on a FACSSCAN. The mean fluorescent intensity value
for each sample was measured. The surface expression
levels of mutant S proteins were expressed as the per-
centage of the mean fluorescent intensity values for the
wild-type S protein after subtracting the background.
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